HopeStage
Back to all studies
UnknownNCT06590025

Study the Efficacy and Safety of the INtegral Cognitive REMediation Program (INCREM) for Depression

Behavioural studyAges 18+Spain
The study in practice

Understand this study

Who could participate?

This study is for people with depression. Listed age limits: from 18 years. Other eligibility criteria apply.

Listed locations
BarcelonaSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: September 13, 2023
Recruitment status
Unknown
Enrollment listed in the registry
296
Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Sponsor type
Hospital / academic medical center
Study type
Behavioral
Intervention type
Behavioural
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
Spain
Age range
Over 18 Years
Official registry ID
NCT06590025
Official title
Show the full official title

A Phase III, Randomized, Active Comparator-controlled, Clinical Trial to Study the Efficacy and Safety of the INtegral Cognitive REMediation Program (INCREM) in Patients with Depression

Recruitment & locations

Status unknown

Barcelona

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, a hospital or academic medical center.

Who can participate?

This study is for people with depression. Listed age limits: from 18 years. Other eligibility criteria apply.

Want to explore more studies?

Explore studies